Abstract
Decreased susceptibility ofK. lactis mutants impaired in the function of cytochromec, cytochromec 1 and cytochrome-c oxidase to fluconazole, bifonazole and amphotericin B in comparison with the isogenic wild-type strain was observed. Flow cytometry with rhodamine 6G did not show any changes in the accumulation of the dye in the mutant cells compared with the corresponding wild-type strain. Sterol analysis showed similar overall amount of sterols in both wild-type and mutant cells. Taking into account the increased amphotericin B resistance and significantly diminished susceptibility of mutant cells to lyticase digestion, the cell wall structure and/or composition may probably be responsible for the observed changes in the susceptibility of mutants to the antifungal compounds used.
Similar content being viewed by others
Abbreviations
- AMB:
-
amphotericin B
- BIF:
-
bifonazole
- FACS:
-
fluorescence-activated cell sorter
- YNB:
-
yeast nitrogen base (medium)
- YPD:
-
yeast extract-peptone dextrose
- ITR:
-
itraconazole
- FLC:
-
fluconazole
- NYS:
-
nystatin
- R6G:
-
rhodamine 6G
- GC:
-
gas chromatography
- YNB MM:
-
YNB minimal medium
References
Agarwal A.K., Rogers P.D., Baerson S.R., Jacob M.R., Barker K.S., Cleary J.D., Walker L.A., Nagle D.G., Clark A.M.: Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents inSaccharomyces cerevisiae.J.Biol.Chem. 12, 34998–35015 (2003).
Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., Struhl K.:Current Protocols in Molecular Biology. John Wiley & Sons, New York 1989.
Bahmed K., Bonaly R., Coulon J.: Relation between cell wall chitin content and susceptibility to amphotericin B inKluyveromyces, Candida andSchizosaccharomyces species.Res.Microbiol. 154, 215–222 (2003).
Balzi E., Chen W., Ulaszewski S., Capieaux E., Goffeau A.: The multidrug resistance genePDR1 fromSaccharomyces cerevisiae.J.Biol.Chem. 262, 16871–16879 (1987).
Baysal B.E., Ferrel R.E., Willet-Brozick J.E., Lawrence E.C., Myssiorek D., Bosch A., van der Mey A., Taschner P.E., Rubinstein W.S., Myers E.N., Richard C.W. 3rd,Cornelisse C.J., Devilee P., Devlin B.: Mutations inSDHD, a mitochondrial complex II gene in hereditary paraglioma.Science 287, 848–851 (2000).
Bialková A., Šubík J.: Biology of the pathogenic yeastCandida glabrata.Folia Microbiol. 51, 3–20 (2006).
Brun S., Aubry C., Lima O., Filmon R., Berges T., Chabasse D., Bouchara J.P.: Relationship between respiration and susceptibility to azole antifungals inCandida glabrata.Antimicrob.Agents Chemother. 47, 847–853 (2003).
Brun S., Berges T., Poupard P., Vauzelle-Moreau C., Renier G., Chabasse D., Bouchara J.P.: Mechanisms of azole resistance in petite mutants ofCandida glabrata.Antimicrob.Agents Chemother. 48, 1788–1796 (2004).
Butow R.A., Avadhani N.G.: Mitochondrial signaling: the retrograde response.Mol.Cell. 14, 1–15 (2004).
Chen X.J., Wesolowski-Louvel M., Fukuhara H.: Glucose transport in the yeastKluyveromyces lactis. II. Transcriptional regulation of the glucose transporter geneRAG1.Mol.Gen.Genet. 233, 97–105 (1992).
Cortopassi G.A., Wong A.: Mitochondria in organismal aging and degeneration.Biochim.Biophys.Acta 1410, 183–193 (1999).
De Nobel J.G., Klis F.M., Priem J., Munnik T., van den Ende H.: The glucanase-soluble mannoproteins limit cell wall porosity inSaccharomyces cerevisiae.Yeast 6, 491–499 (1990).
Defontaine A., Bouchara J.P., Declerk P., Planchenault C., Chabasse D., Hallet J.N.:In vitro resistance to azoles associated with mitochondrial DNA deficiency inCanadida glabrata.J.Med.Microbiol. 48, 663–670 (1999).
Delahodde A., Delaveau T., Jacq C.: Positive autoregulation of the yeast transcription factor Pdr3p, which is involved in control of drug resistance.Mol.Cell.Biol. 15, 4043–4051 (1995).
Delaveau T., Jacq C., Perea J.: Sequence of a 12.7-kb segment of yeast chromosome II identifies aPDR-like gene and several new open reading frames.Yeast 8, 761–768 (1992).
DeRisi J., van den Hazel B., Marc P., Balzi E., Brown P., Jacq C., Goffeau A.: Genome microarray analysis of transcriptional activation in multidrug resistance yeast mutants.FEBS Lett. 470, 156–160 (2000).
Devaux F., Carvajal E., Moye-Rowley S., Jacq C.: Genome-wide studies on the nuclearPDR3-controlled response to mitochondrial dysfunction in yeast.FEBS Lett. 515, 25–28 (2002).
Džugasová V., Šubík J.: Synthetic lethal interaction between thepel1 andop1 mutations inSaccharomyces cerevisiae.Folia Microbiol. 50, 293–299 (2005).
Epstein C.B., Waddle J.A., Hale W. 4th,Dav V., Thornton J., Macatee T.L., Garner H.R., Butow R.A.: Genome-wide responses to mitochondrial dysfunction.Mol.Biol.Cell 12, 297–308 (2001).
Evans I.H., Diala E.S., Earl A., Wilkie D.: Mitochondrial control of cell surface characteristics inSaccharomyces cerevisiae.Biochim.Biophys.Acta 602, 201–206 (1980).
Gbelská Y., Horváthová K., van der Aart Q.J.M., Zonneveld B.J.M., Steensma H.Y., Šubík J.: Isolation and molecular analysis of the gene for cytochromec 1 fromKluyveromyces lactis.Curr.Genet. 30, 145–150 (1996).
Green D.R., Reed J.C.: Mitochondria and apoptosis.Science 281, 1309–1312 (1998).
Hallstrom T.C., Moye-Rowley S.W.: Multiple signals from dysfunctional mitochondria activate the pleiotropic drug resistance pathway inSaccharomyces cerevisiae.J.Biol.Chem. 275, 37347–37356 (2000).
Hapala I., Klobučníková V., Mazáňová K., Kohút P.: Two mutants selectively resistant to polyenes reveal distinct mechanisms of antifungal activity by nystatin and amphotericin B.Biochem.Soc.Trans. 33, 1206–1209 (2005).
Henry K.W., Nickels J.T., Edlind T.D.: Upregulation ofERG genes inCandida species by azoles and other sterol biosynthesis inhibitors.Antimicrob.Agents Chemother. 44, 2693–2700 (2000).
Heus J.J., Zonneveld B.J.M., Steensma H.Y., van den Berg J.A.: Centromeric DNA ofKluyveromyces lactis.Curr.Genet. 18, 517–522 (1990).
Hikkel I., Gbelská Y., van der Aart Q.J.M., Lubec G., Šubík J.: Cloning and characterization ofKICOX18, a gene required for activity of cytochrome-c oxidase inKluyveromyces lactis.Curr.Genet. 32, 267–272 (1997).
Iung A.R., Coulon J., Kiss F., Ekome J.N., Vallner J., Bonaly R.: Mitochondrial function in cell wall glycoprotein synthesis inSaccharomyces cerevisiae NCYC 625 (wild type) and [ρ0] mutants.Appl.Environ.Microbiol. 65, 5398–5402 (1999).
Jia Y., Rothermel B., Thornton J., Butow R.A.: A basic helix-loop-helix zipper transcription complex functions in a signaling pathway from mitochondria to the nucleus.Mol.Cell.Biol. 17, 1110–1117 (1997).
Kaur R., Castano I., Cormack B.P.: Functional genomic analysis of fluconazole susceptibility in the pathogenic yeastCandida glabrata: roles of calcium signaling and mitochondria.Antimicrob.Agents Chemother. 48, 1600–1613 (2004).
Kelly S.L., Lamb D.C., Kelly D.E., Manning N.J., Loeffler J., Hebart H., Schumacher U., Einsele H.: Resistance to fluconazole and cross-resistance to amphotericin B inCandida albicans from AIDS patients caused by defective sterol Δ5,6-desaturation.FEBS Lett. 400, 80–82 (1997).
Kelly S.L., Lamb D.C., Kelly D.E.: Y132H substitution inCandida albicans sterol 14α-demethylase confers fluconazole resistance by preventing binding to haem.FEMS Microbiol.Lett. 180, 171–175 (1999).
Kolaczkowski M., van der Rest M., Cybularz-Kolaczkowska A., Soumillion J.P., Konings W.N., Goffeau A.: Anticancer drugs, ionophoric peptides, and steroids as substrates of the yeast multidrug transporter Pdr5p.J.Biol.Chem. 271, 31543–31548 (1996).
Kontoyiannis D.P.: Modulation of fluconazole sensitivity by the interaction of mitochondria and Erg3p inSaccharomyces cerevisiae.J.Antimicrob.Chemother. 46, 191–197 (2000).
Lees N.D., Bard M., Kirsch D.R.: Biochemistry and molecular biology of sterol synthesis inSaccharomyces cerevisiae.Crit.Rev.Biochem.Mol.Biol. 34, 33–47 (1999).
Liao X., Butow R.A.:RTG1 andRTG2: two yeast genes required for a novel path of communication from mitochondria to the nucleus.Cell 72, 61–71 (1993).
Lussier M., White A.M., Sheraton J., di Paolo T., Treadwell J., Southard S.B., Horenstein C.I., Chen-Weiner J., Ram A.F.J., Kapteyn J.C., Roemer T.W., Vo D.H., Bondoc D.C., Hall J., Zhong W.W., Sdicu A.M., Davies J., Klis F.M., Robbins P.W., Bussey H.: Large scale identification of genes involved in cell surface biosynthesis and architecture inSaccharomyces cerevisiae.Genetics 147, 435–450 (1997).
Miyazaki H., Miyazaki Y., Geber A., Parkinson T., Hitchcock C., Falconer D., Ward J., Marsden K., Bennett J.E.: Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene,PHD1, inCandida glabrata.Antimicrob.Agents Chemother. 42, 1695–1701 (1998).
Moye-Rowley W.S.: Retrograde regulation of multidrug resistance inSaccharomyces cerevisiae.Gene 354, 15–21 (2005).
Prasad R., De Wergifosse P., Goffeau A., Balzi E.: Molecular cloning and characterization of a novel gene ofCandida albicans, CDR1, conferring multiple resistance to drugs and antifungals.Curr.Genet. 27, 320–329 (1995).
Ramanandraibe E., Younsi M., Coulon J., Loppinet V., Hakkou A., Bonaly R.: Implication of cell wall constituents in the sensitivity ofKluyveromyces lactis strains to amphotericin B.Res.Microbiol. 149, 109–118 (1998).
Sanglard D., Ischer F., Monod M., Bille J.: Cloning ofCandida albicans genes conferring resistance to azole antifungal agents: characterization ofCDR2, a new multidrugABC transporter gene.Microbiology 143, 405–416 (1997).
Sanglard D., Ischer F., Calbrese D., Majcherczyk P.A., Bille J.: Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals inCandida glabrata.Antimicrob.Agents Chemother. 45, 1174–1183 (2001).
Sardari S., Mori Y., Kurosawa T., Daneshtalab M.: Modulatory effect of cAMP on fungal ergosterol level and inhibitory activity of azole drugs.Can.J.Microbiol. 49, 344–349 (2003).
Šarinová M., Tichá E., Obernauerová M., Gbelská Y.: Impact of mitochondrial function on yeast susceptibility to antifungal compounds.Folia Microbiol. 52, 223–229 (2007).
Seo K., Akiyoshi H., Ohnishi Y.: Alterations of cell wall composition leads to amphotericin B resistance inAspergillus flavus.Microbiol.Immunol. 43, 1017–1025 (1999).
Takáčová M., Sklenár P., Gbelská Y., Breunig K.D., Šubík J.: Isolation, heterological cloning and sequencing of theRPL28 gene inKluyveromycers lactis.Curr.Genet. 42, 21–26 (2002).
Traven A., Wong J.M.S., Xu D., Sopta M., Ingles J.: Interorganellar communication. Altered nuclear gene expression profiles in a yeast mitochondrial DNA mutant.J.Biol.Chem. 276, 4020–4027 (2001).
Tsai H.-F., Krol A.A., Sarti K.E., Bennet J.E.:Candida glabrata PDR1, a transcriptional regulator of a pleiotropic drug resistance network, mediates azole resistance in clinical isolates andpetite mutants.Antimicrob.Agents Chemother. 50, 1384–1392 (2006).
Van den Bossche H., Marichal P., Gorrens J., Bellens D., Moereels H., Janssen P.A.: Mutation in cytochrome P-450 dependent 14α-demethylase results in decreased affinity for azole antifungals.Biochem.Soc.Trans. 18, 56–59 (1990).
Van Den Hazel H.B., Pichler H., do Valle Matta M.A., Leitner E., Goffeau A., Daum G.:PDR16 andPDR17, two homologous genes ofSaccharomyces cerevisiae, affect lipid biosynthesis and resistance to multiple drugs.J.Biol.Chem. 274, 1934–1941 (1999).
Wallace D.C.: Mitochondrial diseases in man and mouse.Science 283, 1482–1488 (1999).
Yoshida Y., Aoyama Y.: Interaction of azole antifungal agents with cytochrome P-450 14DM purified fromSaccharomyces cerevisiae microsomes.Biochem.Pharmacol. 36, 229–235 (1987).
Zhang X., Moye-Rowley W.S.:Saccharomyces cerevisiae multidrug resistance gene expression inversely correlates with the status of the FO component of the mitochondrial ATPase.J.Biol.Chem. 276, 47844–47852 (2001).
Zhang X., Kolaczkowska A., Devaux F., Panwar S.L., Halstrom T.C., Jacq C., Moye-Rowley W.S.: Transcriptional regulation by Lge1p requires a function independent of its role in H2B ubiquitination.J.Biol.Chem. 280, 2759–2770 (2005).
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by grant no. 1/2338/05 from theSlovak Grant Agency of Science VEGA and grants of theComenius University in Bratislava UK/129/07 and UK/145/07.
Rights and permissions
About this article
Cite this article
Šarinová, M., Straková, V., Balková, K. et al. Decreased susceptibility to antifungals in respiratory-deficientKluyveromyces lactis mutants. Folia Microbiol 52, 484–490 (2007). https://doi.org/10.1007/BF02932108
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02932108